TIM
DTIL icon

Tortoise Investment Management’s Precision BioSciences DTIL Stock Holding History

Tortoise Investment Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed -$1K – 602
2021
Q1 		$1K Buy
+4
New +$1.4K ﹤0.01% 564
2020
Q4 		– Sell
-4
Closed -$1K – 542
2020
Q3 		$1K Hold
4
– – ﹤0.01% 505
2020
Q2 		$1K Hold
4
– – ﹤0.01% 483
2020
Q1 		$1K Hold
4
– – ﹤0.01% 511
2019
Q4 		$2K Buy
+4
New +$1.26K ﹤0.01% 528

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tortoise Investment Management's DTIL Position: Q2 2021 in Review

Tortoise Investment Management sold out of Precision BioSciences (DTIL) in Q2 2021, closing a stake of 4 shares — an estimated $1K sold.

Tortoise Investment Management first reported a position in DTIL in Q4 2019 and held it in 5 quarters. The position peaked at $2K in Q4 2019. 130 funds tracked by Wall St. Rank hold DTIL as of Q2 2021.

  • Tortoise Investment Management reported no remaining Precision BioSciences position as of Q2 2021 after selling out during the quarter.
  • Tortoise Investment Management sold 4 Precision BioSciences shares in Q2 2021, an estimated $1K.
  • Tortoise Investment Management first reported a position in Precision BioSciences in Q4 2019 and held it in 5 quarters.
  • Tortoise Investment Management's Precision BioSciences position peaked at $2K in Q4 2019.
  • 130 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2021.

Based on Tortoise Investment Management's 13F filing for Q2 2021, filed 30 Jul 2021.